Agonist-antagonist activity of anti-estrogens in the human breast cancer cell line MCF-7: an hypothesis for the interaction with a site distinct from the estrogen binding site

This publication has 29 references indexed in Scilit:

• Switching agonistic, antagonistic, and mixed transcriptional responses to 11 beta-substituted progestins by mutation of the progesterone receptor
  Molecular Endocrinology, 1992
• Antagonistic effect of triphenylethylenic antiestrogens on the association of estrogen receptor to calmodulin
  Biochemical and Biophysical Research Communications, 1992
• Estrogenic effect of phenol red in MCF-7 cells is achieved through activation of estrogen receptor by interacting with a site distinct from the steroid binding site
  Biochemical and Biophysical Research Communications, 1987
• The design and use of sex-steroid antagonists
  Journal of Steroid Biochemistry, 1986
• Radioligand, agonists and membrane receptors on intact cells: data analysis in a bind
  Trends in Pharmacological Sciences, 1985
• Identification of immunoassayable estrogen receptor lacking hormone binding ability in tamoxifen-treated rat uterus
  Biochemical and Biophysical Research Communications, 1985
• Antiestrogen action in breast cancer cells: Modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites
  Breast Cancer Research and Treatment, 1985
• Estrogenic effect of tamoxifen and its derivatives on the proliferation of MCF7 human breast tumor cells
  Life Sciences, 1985
• Influence of new hydroxylated Triphenylethylene (TPE) derivatives on estradiol binding to uterine cytosol
  Journal of Steroid Biochemistry, 1984
• Tumor growth-stimulating and inhibiting effects of antiestrogens on the DMBA-induced mammary carcinoma of the ovariectomized, diethylstilbestrol-treated SD rat. A study on the mechanism of action of antiestrogens
  European Journal of Cancer and Clinical Oncology, 1983